Join the Orphenadrine group to help and get support from people like you.
Orphenadrine News
FDA Medwatch Alert: Sandoz, Inc. Issues Nationwide Recall of 13 Lots of Orphenadrine Citrate 100 mg Extended Release Tablets Due to Presence of a Nitrosamine Impurity
March 22, 2022 – Princeton, NJ, Sandoz Inc. (“Sandoz”) is initiating a voluntary recall of 13 lots (listed below) of oral Orphenadrine Citrate 100 mg Extended Release (ER) Tablets to the consumer lev...
Further information
Related condition support groups
Muscle Spasm, Migraine, Headache